Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Rasmussen TA, Tolstrup M, Brinkmann C, Olesen R, Erikstrup C, Solomon A, Winkelmann A, Palmer SE, Dinarello CA, Buzon MJ, Lichterfield M, Lewin SR, Østergaard LJ, SØgaard OS

(2014), Lancet HIV, 1(1), e13-21

Determinants of suicide and accidental or violent death in the Australian HIV Observational Database

McManus H, Petoumenos K, Franic T, Kelly MD, Watson J, O'Connor CC, Jeanes M, Hoy J, Cooper DA, Law MG; Australian HIV Observational Database

(2014), PLoS One, 9(2), e89089

Medical graduates' knowledge of bloodborne viruses and occupational exposures

Koehler N, Vujovic O, Dendle C, McMenamin C

(2014), Am J Infect Control, 42(2), 203-5

The significance of HIV 'blips' in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)

Kanapathipillai R, McManus H, Kamarulzaman A, Lim PL, Templeton DJ, Law M, Woolley I.

(2014), PLoS One, 9(2), e86122

Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy

Haskelberg H, Mallon PW, Hoy J, Amin J, Moore C, Phanuphak P, Ferret S, Belloso WH, Boyd MA, Cooper DA, Emery S

(2014), J Acquir Immune Defic Syndr, 67(2), 161-8

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA; International Antiviral Society-USA Panel

(2014), JAMA, 312(4), 410-25

Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study

Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ; INSIGHT SMART Study Group

(2014), J Electrocardiol, 47(2), 264-71

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

Bloch M, Tong WW, Hoy J, Baker D, Lee FJ, Richardson R, Carr A; TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team

(2014), HIV Med, 15(6), 373-80

CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals

Bastidas S, Graw F, Smith MZ, Kuster H, Günthard HF, Oxenius A

(2014), J Immunol, 192(4), 1732-44

What has the Young Physician Leaders Programme achieved?

Giles ML, Vincent FB, Volkenstein S, Shefin SM, Silva A, Fredrick F; Young Physician Leadership Group 2013

(2014), Lancet, 384(9937), 26-7

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY

(2014), Transpl Infect Dis, 16(6), 887-96

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, Heath CH, Grigg A, Bardy PG, Kwan J, Kirsa SW, Slavin M, Gottlieb T, Chen S

(2014), Intern Med J, 44(12b), 1298-314

Bringing new HIV infections to zero - opportunities and challenges offered by antiretroviral-based prevention in Asia, the Pacific and beyond: An overview of this special issue

Zablotska IB, Whittaker B, de Wit J, Kamarulzaman A, Ananworanich J, Wright E, Poynten IM, Mayer K

(2014), Sex Health, 11(2), 97-100

Neuro OIs: developed and developing countries

Wright EJ

(2014), Curr Opin HIV AIDS, 9(6), 539-44

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

Woolley IJ, Ayoub S, Crowe SM, Westhorpe C, Cherry CL, Visvanathan K, Morand E

(2014), AIDS, 28(11), 1693-4

The maturation of antibody technology for the HIV epidemic

Winnall WR, Beasley MD, Center RJ, Parsons MS, Kiefel BR, Kent SJ

(2014), Immunol Cell Biol, 92(7), 570-7

Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes

Tan HY, Yong YK, Lim SH, Ponnampalavanar S, Omar SF, Pang YK, Kamarulzaman A, Price P, Crowe SM, French MA

(2014), Sex Health, 11(6), 532-9

No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial

Solomon A, Tennakoon S, Leeansyah E, Arribas J, Hill A, Van Delft Y, Moecklinghoff C, Lewin SR

(2014), PLoS One, 9(11), e109718

Systematic review of the performance of HIV viral load technologies on plasma samples

Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perrins J, Peeling RW

(2014), PLoS One, 9(2), e85869

Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis

Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perriens JH, Peeling RW

(2014), PLoS One, 9(3), e86461

32 33 34 35 36